Details for New Drug Application (NDA): 208412
✉ Email this page to a colleague
The generic ingredient in PREDNISONE is prednisone. There are sixteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the prednisone profile page.
Summary for 208412
Tradename: | PREDNISONE |
Applicant: | Strides Pharma |
Ingredient: | prednisone |
Patents: | 0 |
Pharmacology for NDA: 208412
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 208412
Suppliers and Packaging for NDA: 208412
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PREDNISONE | prednisone | TABLET;ORAL | 208412 | ANDA | QPharma Inc | 42708-166 | 42708-166-21 | 21 TABLET in 1 BOTTLE, PLASTIC (42708-166-21) |
PREDNISONE | prednisone | TABLET;ORAL | 208412 | ANDA | Medsource Pharmaceuticals | 45865-884 | 45865-884-21 | 21 TABLET in 1 BOTTLE (45865-884-21) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Feb 11, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Feb 11, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Jan 11, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription